Dataset Information


Glucagon-like peptide-1 receptor agonist Liraglutide has anabolic bone effects in ovariectomized rats without diabetes.

ABSTRACT: Recently, a number of studies have demonstrated the potential beneficial role for novel anti-diabetic GLP-1 receptor agonists (GLP-1RAs) in the skeleton metabolism in diabetic rodents and patients. In this study, we evaluated the impacts of the synthetic GLP-1RA Liraglutide on bone mass and quality in osteoporotic rats induced by ovariectomy (OVX) but without diabetes, as well as its effect on the adipogenic and osteoblastogenic differentiation of bone marrow stromal cells (BMSCs). Three months after sham surgery or bilateral OVX, eighteen 5-month old female Wistar rats were randomly divided into three groups to receive the following treatments for 2 months: (1) Sham + normal saline; (2) OVX + normal saline; and (3) OVX + Liraglutide (0.6 mg/day). As revealed by micro-CT analysis, Liraglutide improved trabecular volume, thickness and number, increased BMD, and reduced trabecular spacing in the femurs in OVX rats; similar results were observed in the lumbar vertebrae of OVX rats treated with Liraglutide. Following in vitro treatment of rat and human BMSCs with 10 nM Liraglutide, there was a significant increase in the mRNA expression of osteoblast-specific transcriptional factor Runx2 and the osteoblast markers alkaline phosphatase (ALP) and collagen ?1 (Col-1), but a significant decrease in peroxisome proliferator-activated receptor ? (PPAR?). In conclusion, our results indicate that the anti-diabetic drug Liraglutide can exert a bone protective effect even in non-diabetic osteoporotic OVX rats. This protective effect is likely attributable to the impact of Liraglutide on the lineage fate determination of BMSCs.


PROVIDER: S-EPMC4503456 | BioStudies | 2015-01-01

REPOSITORIES: biostudies

Similar Datasets

2016-01-01 | S-EPMC5199056 | BioStudies
2017-01-01 | S-EPMC5701180 | BioStudies
2019-01-01 | S-EPMC6589309 | BioStudies
2019-01-01 | S-EPMC6893723 | BioStudies
2016-01-01 | S-EPMC4957106 | BioStudies
2016-01-01 | S-EPMC5141561 | BioStudies
2015-01-01 | S-EPMC6728679 | BioStudies
2020-01-01 | S-EPMC7401263 | BioStudies
2018-01-01 | S-EPMC6248888 | BioStudies
1000-01-01 | S-EPMC5356343 | BioStudies